BRAIN Biotech AG
XETRA:BNN
BRAIN Biotech AG
Free Cash Flow
BRAIN Biotech AG
Free Cash Flow Peer Comparison
Competitive Free Cash Flow Analysis
Latest Figures & CAGR of Competitors
Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
BRAIN Biotech AG
XETRA:BNN
|
Free Cash Flow
€-4.8m
|
CAGR 3-Years
15%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
Wacker Chemie AG
XETRA:WCH
|
Free Cash Flow
€296.7m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
24%
|
CAGR 10-Years
-4%
|
|
Evonik Industries AG
XETRA:EVK
|
Free Cash Flow
€801m
|
CAGR 3-Years
1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
Covestro AG
XETRA:1COV
|
Free Cash Flow
€232m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
N/A
|
|
AlzChem Group AG
XETRA:ACT
|
Free Cash Flow
€52.1m
|
CAGR 3-Years
38%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Symrise AG
XETRA:SY1
|
Free Cash Flow
€433.5m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
16%
|
CAGR 10-Years
12%
|
See Also
What is BRAIN Biotech AG's Free Cash Flow?
Free Cash Flow
-4.8m
EUR
Based on the financial report for Dec 31, 2023, BRAIN Biotech AG's Free Cash Flow amounts to -4.8m EUR.
What is BRAIN Biotech AG's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
3%
Over the last year, the Free Cash Flow growth was -45%. The average annual Free Cash Flow growth rates for BRAIN Biotech AG have been 15% over the past three years , 3% over the past five years .